AI assistant
Oncopeptides Major Shareholding Notification 2024
3091_iss_2024-05-16_45e7ebee-9d2c-40fa-bce1-e43176358d1e.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Oncopeptides AB
Holder
Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension
| Instrument |
|---|
| ------------ |
| Instrument | Aktier | |
|---|---|---|
| Before the transaction | ||
| Shares | Data not given Data not given |
|
| Voting rights | ||
| Transaction | ||
| Reason for major shareholding notification New share issue | ||
| Date | 15/05/2024 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 7,617,132 | |
| Directly held voting rights | 0 | |
| Indirectly held voting rights | 7,617,132 | |
| Percentage | ||
| Directly held shares | 3.53979 % | |
| Directly held voting rights | 0 % | |
| Indirectly held voting rights | 3.60247 % | |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 3.60247 % | 7,617,132 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | 4.07591 % | 8,618,184 |
| Total | 7.67838 % | 16,235,316 |
Group total holdings
Voting rights 16,235,316 Percentage of voting rights 7.67838
Notes (other relevant informations according to law)
Flaggning sker för passerat tröskelvärde beträffande det aggregerade innehavet. Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Innehavet är beräknat på 215 186 246 utestående aktier och 211 441 841 röster.
Published
16/05/2024 10:38
Contact
Name Marie Karlsfeldt
Email [email protected]
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25